5 Facts about pharmacogenomics genetic testing (without the hype)

What is Pharmacogenomics?

Pharmacogenomics (PGx) studies the association between genetic variants and drug metabolism and has many advantages for the field of precision medicine. Some genetic variations can cause individuals to metabolize drugs more slowly or quickly, which can affect the effectiveness of the medication and increase the risk of side effects. Adoption of PGx in clinical and diagnostic environments is continuing to gain traction as knowledgebases and novel genetic insights continue to improve.  

How drugs metabolize in the body

 

  1. 1. Metabolism: Some genes code for enzymes that metabolize drugs in the body. Genetic variations in these enzymes can affect the rate at which drugs are metabolized, which can impact the effectiveness of medication and increase the risk of side effects.

  2.  

  1. 2. Transport: Genes can also code for proteins that transport drugs across cell membranes. Genetic variations in these proteins can affect the amount of drugs that get into cells, which can impact the effectiveness of medication.

  2.  

  1. 3. Receptors: Some genes code for receptors that drugs bind to in order to exert their effects. Genetic variations in these receptors can affect the way drugs bind and interact with the body, which can impact the effectiveness of medication and the risk of side effects.

  2.  

  1. 4. Inflammation: Genes are involved in inflammatory responses, which can affect the way drugs act in the body. 

  1. Tolerance: Genetic variations can also affect the development of tolerance to certain drugs, particularly in the case of opioids, alcohol, and some psychostimulants.

  2.  

  1. 5. Interactions: Some genetic variations can also affect the way drugs interact with other drugs, food, or supplements, which can impact the effectiveness of medication and increase the risk of side effects. 

 

Accurate or Not accurate: pharmacogenetic genetic tests 

 

Pharmacogenetic genetic tests are generally considered to be accurate, but the accuracy of a test can depend on several factors, such as the specific test being used, the quality of the laboratory performing the test, and the population being tested. 

  1. Test accuracy: Different pharmacogenetic tests have different levels of accuracy. Some tests are more accurate than others, and the accuracy of a test can depend on the specific genetic variant being tested. 

  2.  
  1. Laboratory quality: The quality of the laboratory performing the test is also important. Labs that are accredited by the College of American Pathologists (CAP) or the Clinical Laboratory Improvement Amendments (CLIA) are considered to have high standards for quality. 

  2.  
  1. Population: The population being tested can also affect the accuracy of a test. Some genetic variations are more common in certain populations than others, and the accuracy of a test may vary depending on the population being tested. 

  2.  
  1. Interpretation: The interpretation of the results of the test is also important. Some genetic variations have a well-established relationship with drug response and some have not. Therefore, healthcare providers should be familiar with the latest guidelines and the level of evidence behind the test they are ordering. 

  2.  
  1. Validation: It’s also important to keep in mind that not all pharmacogenetics tests have been validated in large clinical studies, which means that the clinical utility of some tests may be uncertain. 

 

Interpreting pharmacogenomics with Geneyx 

 

The Geneyx PGx workflow offers comprehensive interpretations for 13 CPIC level A/B and PharmgKB level 1/2 genes that affect the metabolism of 68 commonly prescribed drugs. This information is consolidated from multiple annotation sources, including Clinical Pharmacogenomic Implementation Consortium (CPIC), Food and Drug Administration (FDA), and the Pharmacogenomics Knowledge Base (PharmGKB). For every gene reported there are also useful hyperlinks to these databases, all of which are automatically pulled into the report.  

 

The Geneyx PGx report includes detailed patient and drug information that is easy to comprehend and fully customizable. Genes can be easily excluded from the report if they have low quality or missing SNPs and final modifications to the report can be performed in the report editor with electronic signature sign off. In more detail, the report will display the gene name, genotype, and the impact of the genetic changes on drug metabolism. This is combined with gene descriptions that explain the gene’s function, its association with drug metabolism, and the effect of gene changes on therapeutic effectiveness. 

 

Together, the Geneyx Pharmacogenomics workflow gives users powerful insights to mitigate potentially adverse drug reactions and metabolic responses by harnessing key databases and unique genetic profiles. If affiliated with a clinical or diagnostic company and are interested in providing PGx reports to patients, please schedule a meeting to see the Geneyx PGx workflow in real time.  

 

 

Contact us and expand your knowledge on our platform 

Additional Posts

Blog

Top 12 Genetics Conferences in 2023 You Must Attend

Are you to meet people (face-to-face), connect, learn, grow, and be inspired? Here are our 12 Conferences to keep your eyes on 2023.

Geneyx Analysis Ver. 512

New Ver. 5.12 Updates to Whole Genome Sequencing Analysis

Geneyx Analysis has been updated. Take a look at the improvements you can make to Whole Genome Sequencing Analysis.

5 Facts about pharmacogenomics genetic testing (without the hype)

Pharmacogenomics (PGx) studies the association between genetic variants and drug metabolism. We are now in the market.

Analysis Report

Geneyx Analysis Version 5.10 Release

The Variant Browser now supports the lookup of copy number and structural variants (CNV/SV). With this feature, users can query events based on relevant annotations, including events that overlap

WGS Diagnoses

Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis.

What is better as an initial test WES or WGS? A recent paper in the European Journal of Human Genetics put this notion to the test. They found

Version 5.9 notes

Geneyx Analysis Version 5.9 Release

With more than 300 accounts and close to 200,000 cases analyzed, Geneyx Analysis is continuing to receive global adoption in clinical and academic settings. One differentiating feature that advances

Previous
Next

Top 12 Genetics Conferences in 2023 You Must Attend

Are you to meet people (face-to-face), connect, learn, grow, and be inspired? Here are our 12 Conferences to keep your eyes on 2023.

Geneyx Analysis Ver. 512

New Ver. 5.12 Updates to Whole Genome Sequencing Analysis

Geneyx Analysis has been updated. Take a look at the improvements you can make to Whole Genome Sequencing Analysis.

5 Facts about pharmacogenomics genetic testing (without the hype)

Pharmacogenomics (PGx) studies the association between genetic variants and drug metabolism. We are now in the market.

Analysis Report

Geneyx Analysis Version 5.10 Release

The Variant Browser now supports the lookup of copy number and structural variants (CNV/SV). With this feature, users can query events based on relevant annotations, including events that overlap

WGS Diagnoses

Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis.

What is better as an initial test WES or WGS? A recent paper in the European Journal of Human Genetics put this notion to the test. They found

Version 5.9 notes

Geneyx Analysis Version 5.9 Release

With more than 300 accounts and close to 200,000 cases analyzed, Geneyx Analysis is continuing to receive global adoption in clinical and academic settings. One differentiating feature that advances

+

Selected Videos

Previous
Next